- $77.68bn
- $95.83bn
- £31.38bn
- 70
- 76
- 75
- 86
REG - GlaxoSK Capital PLC - Publication of a Prospectus
AnnouncementREG - GlaxoSmithKline PLC - GSK’s Zejula approved in first-line ovarian cancer
AnnouncementREG - GlaxoSmithKline PLC - 1st Quarter Results
AnnouncementREG - GlaxoSmithKline PLC - Arrangements for Shareholder Webcast
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Sanofi and GSK collaboration to fight COVID-19
AnnouncementREG - GlaxoSmithKline PLC - AGM - Change of Arrangements
AnnouncementREG - GlaxoSmithKline PLC - GSK and Vir Biotechnology enter collaboration
AnnouncementREG - GlaxoSmithKline PLC - GSK completes divestment of Horlicks
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Consumer Healthcare product sales category changes
AnnouncementREG - GlaxoSmithKline PLC - Second Price Monitoring Extn
AnnouncementREG - GlaxoSmithKline PLC - Price Monitoring Extension
AnnouncementREG - GlaxoSmithKline PLC - Second Price Monitoring Extn
Announcement